HFS
CATX icon

Horizon Financial Services’s Perspective Therapeutics CATX Stock Holding History

Horizon Financial Services’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-35
Closed -$136 – 64
2021
Q4 		$136 Hold
35
– – ﹤0.01% 124
2021
Q3 		$0 Hold
35
– – ﹤0.01% 144
2021
Q2 		$0 Buy
+35
New +$307 ﹤0.01% 136

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TMWM
Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Horizon Financial Services's CATX Position: Q1 2022 in Review

Horizon Financial Services sold out of Perspective Therapeutics (CATX) in Q1 2022, closing a stake of 35 shares — an estimated $136 sold.

Horizon Financial Services first reported a position in CATX in Q2 2021 and held it in 3 quarters. The position peaked at $136 in Q4 2021. 39 funds tracked by Wall St. Rank hold CATX as of Q1 2022.

  • Horizon Financial Services reported no remaining Perspective Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Horizon Financial Services sold 35 Perspective Therapeutics shares in Q1 2022, an estimated $136.
  • Horizon Financial Services first reported a position in Perspective Therapeutics in Q2 2021 and held it in 3 quarters.
  • Horizon Financial Services's Perspective Therapeutics position peaked at $136 in Q4 2021.
  • 39 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2022.

Based on Horizon Financial Services's 13F filing for Q1 2022, filed 27 Apr 2022.